POTENTIAL APPLICATIONS OF Lactobacillus CELL COMPONENTS IN THE BIOTECHNOLOGY OF HUMAN LYMPHOBLASTOID INTERFERON V.V. Pits, O.P. Trokhimenko, V.Yu. Polishchuk, S.O. Soloviov, I.V. Dziublyk, I.M. Fedianovych, Z.F. Kysil, N.A. Bobyr

Details: Hits: 166

ISSN 2410-7751 (Print)
ISSN 2410-776X (Online)

cover biotech acta general

Biotechnologia Acta Т. 18, No. 1, 2025
P. 44-54 , Bibliography 22 , Engl.
UDC: 577.112.385:579.61:615.37
DOI: https://doi.org/10.15407/biotech18.01.044

Full text: (PDF, in English)

POTENTIAL APPLICATIONS OF Lactobacillus CELL COMPONENTS IN THE BIOTECHNOLOGY OF HUMAN LYMPHOBLASTOID INTERFERON

V.V. Pits¹, O.P. Trokhimenko², V.Yu. Polishchuk¹, S.O. Soloviov ^{1, 2}, I.V. Dziublyk^2, I..M. Fedianovych³, Z.F. Kysil³, N.A. Bobyr³

¹Igor Sikorsky Kyiv Polytechnic Institute, Ukraine
²Shupyk National Healthcare University of Ukraine, Kyiv
³Bogomolets National Medical University, Kyiv, Ukraine

Aim. The study aimed to investigate the role of lactobacillus cell components and their effective use in increasing the efficiency of human lymphoblastoid interferon production.

Methods. The study was conducted on the Namalva cell line, a known producer of human lymphoblastoid IFN-α. Newcastle disease virus (NDV) was used as an inducer of interferon production Lactobacillus cell components and metabolites cultured in MRS and its iodine- and Tween-modified variants were evaluated as co-inductors. Macromolecular platinum complexes were used to synchronize Namalva cells in the G1 phase, with synchronization assessed using flow cytometry.

Results. Lactobacillus metabolites grown in MRSjt medium substantially increased interferon production when combined with NDV in synchronized Namalva cultures. The interferon yield increased 16-fold relative to the control. Synchronization of Namalva cells in the G1 phase using macromolecular platinum complex resulted in 96% of cells in the G1 phase, substantially boosting interferon production.

Conclusions. Synchronizing Namalva cells in the G1 phase significantly improved IFN-α production when induced with NDV. The macromolecular platinum complex effectively synchronizes Namalva cells, optimizing interferon production. Lactobacillus metabolites from MRSjt medium serve as cost-effective, natural co-inductors for biotechnological IFN- α production.

Key words: L actobacillus cell components, Human leukocyte interferon-alpha, Namalva cell line, Macromolecular platinum complex.

Referencers

National Center for Biotechnology Information [Internet]. IFNA1 interferon alpha 1 [Homo sapiens (human)] - Gene - NCBI.https://www.ncbi.nlm.nih.gov/gene/3439
Rubinstein, M., Rubinstein, S., Familletti P,.C., Miller, R. S., Waldman, A. A., Pestka, S. (1979). Human leukocyte interferon: production, purification to homogeneity, and initial characterization. National Acad. Sci. [Internet]. 1 Feb. 76(2), 640‒644. https://doi.org/10.1073/pnas.76.2.640
Imanishi, J., Hoshino, S., Matsuoka, H., Kita, M., Kishida, T., Minowada, J. (1982). Production and characterization of human T leukemic lymphoblastoid cell interferon. J. Jun, 25(2), 79-87. PMID: 6182877. https://pubmed.ncbi.nlm.nih.gov/6182877/
Viscomi, G. C., Grimaldi, M., Palazzini, E., Silvestri, S. (1995). Human leukocyte interferon alpha: structure, pharmacology, and therapeutic applications. Med Rev. [Internet]. September. 15(5), 445‒78. https://doi.org/10.1002/med.2610150504
Cantell, K. (1986).Clinical performance of natural human leukocyte interferon. Immunobiology [Internet]. September. 172(3-5), 231-242. https://doi.org/10.1016/s0171-2985(86)80103-6
Production of recombinant interferon proteins WO2009073975A1 https://patents.google.com/patent/WO2009073975A1/en
Cantell, K. (1977). Prospects for the clinical use of exogenous interferon. Biol. Apr;55(2), 69‒73. PMID: 194114. https://pubmed.ncbi.nlm.nih.gov/194114/
Havell, E. A., Vilcek, J. (1972). Production of high-titered interferon in cultures of human diploid cells. Agents Chemother [Internet]. 1 Dec. 2(6), 476‒484. https://doi.org/10.1128/aac.2.6.476
Havell, E. A., Yip, Y.K., Vilcek , J.( 1978). Characteristics of human lymphoblastoid (Namalva) interferon. Gen. Virol. [Internet]. 1 Jan. 38(1), 51‒,9. https://doi.org/10.1099/0022-1317-38-1-51
Heremans, H., de Ley, M., Volckaert-Vervliet, G., Billiau, A. (1980). Interferon production and virus replication in lymphoblastoid cells infected with different viruses. Arch Virol [Internet]. Sept. 63(3‒4), 317‒320. https://doi.org/10.1007/bf01315039
Zoon, K. C., Bridgen, P.J., Smith, M. E. (1979). Production of human lymphoblastoid interferon by namalwa cells cultured in serum-free media. Gen. Virol. [Internet]. 1 Jul. 44(1), 227‒229. https://doi.org/10.1099/0022-1317-44-1-227
Girin, V. M., Dziublyk, I. V., Trokhymenko, O. P. Kovalchuk V. K.. (1999). Reproduction of viruses in cell cultures synchronized by macromolecular platinum complexes. Journal. 61(3), 37‒45
Soloviov, S., Trokhimenko, O., Polishchuk, V., Pits ,V., Vasylenko, V., Vasylenko, Y., Hol, I., Symchuk, A., Kostiuk, O. (2024). In vitro modeling of the effect of lactobacillus metabolites on the systemic response of the body in intestinal viral infection. Innov Biosyst Bioeng [Internet]. 21 June. 8(2), 38-52. https://doi.org/10.20535/ibb.2024.8.2.306587
Lowry, O., Rosebrough, N., Farr, A. L, Randall, R. (1951). Protein measurement with the folin phenol reagent. J Biol Chem [Internet]. 193(1), 265‒275. https://doi.org/10.1016/s0021-9258(19)52451-6
Dziublyk I.V., Trokhymenko O.P., Keysevich L.V. (1997). Method of synchronization of cells in the G1 phase of the cell cycle. Patent No. 24026, Ukraine, MPK6, C12N 5/02; C12N5/00. Bull. Industrial Property of Ukraine. 4, 31.08.98, 247 P. (In Ukrainian).
Drug Directory Compendium [Internet]. (POLYPLATILLENUM*) Active ingredient. https://compendium.com.ua/uk/akt/80/94441/polyplatillenum/.
Burleson, F. G., Chambers, T. M, Wiedbrauk, D. L. (1992). Virology: a laboratory manual. Academic Press, London, pp 244–246. https://books.google.com.ua/books/about/Virology.html?id=5s3SBQAAQBAJ&redir_esc=y https://doi.org/10.1016/B978-0-12-144730-4.50004-7
Lei, C., Yang, J., Hu, J., Sun, X. (2020) On the calculation of TCID50 for quantitation of virus infectivity. Virol SIn [Internet]. 26 May. 36(1), 141–144. https://doi.org/10.1007/s12250-020-00230-5
Directive 2000/54/EC of the European Parliament and of the Council of 18 September 2000 on the protection of workers from risks related to exposure to biological agents at work (seventh individual directive within the meaning of Article 16(1) of Directive 89/391/EEC) Directive 2000/54/EC of the European Parliament and of the Council of 18 September 2000 on the protection of workers from risks related to exposure to biological agents at work (seventh individual directive within the meaning of Article 16(1) of Directive 89/391/EEC). http://data.europa.eu/eli/dir/2000/54/oj
Zoon, K. C., Buckler, C. E., Bridgen, P. J. (1978) Gurari-Rotman D. Production of human lymphoblastoid interferon by Namalva cells. Clin. Microbiol. [Internet]. Jan. 7(1), 44-51. https://doi.org/10.1128/jcm.7.1.44-51.1978
EP 0374267 A1 Platinum (II) derivatives from polyanion of deoxyribonucleic acid, a method for their preparation and a medicinal product with antitumor action based on them / Volchenskova I.I., Maidanevych N.N., Budaryn L.I., Keysevich L.V., Trokhymenko O.P., Shalimov S.O. (International application PCT WO 89/11861. https://patentimages.storage.googleapis.com/30/e1/a9/2b4760e4f7a298/WO1989011861A1.pdf
Chen,Y., Lin, J., Zhao, Y., Ma, X., Yi, H. (2021). Toll-like receptor 3 (TLR3) regulation mechanisms and roles in antiviral innate immune responses. J Zhejiang Univ Sci B [Internet]. July. 22(8), 609-32. https://doi.org/10.1631/jzus.b2000808